Personalized Medicine Coalition Conference​ (PMC 2024)

Wednesday, November 13, 2024
10:45 a.m.

Investing in Diagnostics

Personalized medicine depends on a strong diagnostics industry, which faces an uncertain future. This panel examines the perspectives of investors and senior executives on the financial future of the industry.

MODERATOR | Michael D. Goldberg, Executive Chairman, DNAnexus, Chairman, CareDx

Brian Caveney, M.D., Chief Medical & Scientific Officer, Labcorp

Michael Pellini, M.D., General Partner, S32

Sam Raha, Chief Operating Officer, Myriad Genetics

Matthew Sykes, Managing Director, Life Sciences and Diagnostics Industry Investments, Goldman Sachs